{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:42:18Z","timestamp":1789994538333,"version":"4.0.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"DOI":"10.3389\/fcimb.2018.00438","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T03:38:55Z","timestamp":1546573135000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii"],"prefix":"10.3389","volume":"8","author":[{"given":"Yu-Shan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mozna","family":"Khraiwesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Sciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1517\/21678707.2015.1039510","article-title":"Miltefosine, an FDA-approved drug for the \u2018orphan disease\u2019, leishmaniasis","volume":"3","author":"Berman","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"B2","first-page":"3032","article-title":"Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients","volume":"6","author":"Bocci","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1128\/AAC.28.3.437","article-title":"Antibacterial activities of antineoplastic agents","volume":"28","author":"Bodet","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1128\/EC.00314-12","article-title":"A repurposing approach identifies off-patent drugs with fungicidal Cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of Cryptococcosis","volume":"12","author":"Butts","year":"2013","journal-title":"Eukaryot Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s002530051546","article-title":"Pharmaceutically active secondary metabolites of microorganisms","volume":"52","author":"Demain","year":"1999","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1128\/AAC.01727-13","article-title":"Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital","volume":"58","author":"Deng","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B7","first-page":"204","article-title":"In vitro activity of azithromycin against clinical isolates of Acinetobacter baumannii","volume":"16","author":"Fern\u00e1ndez Cuenca","year":"2003","journal-title":"Rev. Esp. Quimioter."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1128\/JB.00131-15","article-title":"Resources for genetic and genomic analysis of emerging pathogen Acinetobacter baumannii","volume":"197","author":"Gallagher","year":"2015","journal-title":"J. Bacteriol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.ijantimicag.2015.07.017","article-title":"Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin, and vancomycin in Acinetobacter baumannii","volume":"46","author":"Garc\u00eda-Quintanilla","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000238445","article-title":"Effect of 5-fluorouracil, mitoxantrone, methotrexate, and vincristine on the antibacterial activity of ceftriaxone, ceftazidime, cefotiam, piperacillin, and netilmicin","volume":"32","author":"Gieringer","year":"1986","journal-title":"Chemotherapy"},{"key":"B11","doi-asserted-by":"publisher","first-page":"80ps16","DOI":"10.1126\/scitranslmed.3001862","article-title":"The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics","volume":"3","author":"Huang","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e01076","DOI":"10.1128\/mBio.01076-14","article-title":"AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments","volume":"5","author":"Jacobs","year":"2014","journal-title":"MBio"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1600-0447.1992.tb03310.x","article-title":"A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites","volume":"369","author":"Johansson","year":"1992","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"B15","doi-asserted-by":"publisher","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B16","first-page":"5959","article-title":"Phase I trial of parenteral 6-thioguanine given on 5 consecutive days","volume":"46","author":"Kovach","year":"1986","journal-title":"Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens","volume":"2","author":"Lin","year":"2015","journal-title":"EBioMedicine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0076-6879(09)04802-2","article-title":"Chapter 2. From microbial products to novel drugs that target a multitude of disease indications","volume":"458","author":"Marinelli","year":"2009","journal-title":"Methods Enzymol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1634\/theoncologist.2014-0178","article-title":"6-thioguanine: a drug with unrealized potential for cancer therapy","volume":"19","author":"Munshi","year":"2014","journal-title":"Oncologist"},{"key":"B21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12879-015-1297-x","article-title":"Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data","volume":"15","author":"Oikonomou","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1002\/1097-0142(19840615)53:12<2610::AID-CNCR2820531207>3.0.CO;2-9","article-title":"Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine","volume":"53","author":"Presant","year":"1984","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fmicb.2015.00282","article-title":"Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections","volume":"6","author":"Rangel-Vega","year":"2015","journal-title":"Front. Microbiol."},{"key":"B24","first-page":"229","article-title":"Brain dopamine receptors","volume":"32","author":"Seeman","year":"1980","journal-title":"Pharmacol. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2174\/1568026616666160930131737","article-title":"Repurposing of anticancer drugs for the treatment of bacterial infections","volume":"17","author":"Soo","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e116","DOI":"10.1038\/emi.2016.123","article-title":"Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria","volume":"5","author":"Sun","year":"2016","journal-title":"Emerg. Microbes Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0021-9673(98)00635-9","article-title":"Determination of fluspirilene in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation","volume":"828","author":"Swart","year":"1998","journal-title":"J. Chromatogr. A"},{"key":"B28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity, and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4856","DOI":"10.1128\/AAC.05996-11","article-title":"In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates","volume":"56","author":"Vidaillac","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"P40","DOI":"10.1186\/cc6261","article-title":"A multicenter randomized controlled clinical trial comparing central venous catheters impregnated with either 5-fluorouracil or chlorhexidine\/silver sulfadiazine in preventing catheter colonization","volume":"12","author":"Walz","year":"2008","journal-title":"Crit. Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2174\/1875397301004010057","article-title":"A grid algorithm for high throughput fitting of dose-response curve data","volume":"4","author":"Wang","year":"2010","journal-title":"Curr. Chem. Genomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00438-013-0805-1","article-title":"Identification and genetics of 6-thioguanine secreted by Erwinia species and its interference with the growth of other bacteria","volume":"289","author":"Wensing","year":"2014","journal-title":"Mol. Genet. Genomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41426-018-0038-9","article-title":"Analysis of global prevalence of antibiotic resistance in Acinetobacter baumannii infections disclosed a faster increase in OECD countries","volume":"7","author":"Xie","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"B34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/bph.13895","article-title":"Drug repurposing screens and synergistic drug-combinations for infectious diseases","volume":"175","author":"Zheng","year":"2018","journal-title":"Br. J. Pharmacol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T03:38:59Z","timestamp":1546573139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcimb.2018.00438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":34,"alternative-id":["10.3389\/fcimb.2018.00438"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2018.00438","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"article-number":"438"}}